EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Úlcera péptica

Isabel Laucirica, Pilar García Iglesias, Xavier Calvet

Medicina Clínica · 2023

DOI: 10.1016/j.medcli.2023.05.008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicina Clínica, 2023. Verfasst von Isabel Laucirica und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servei d'Aparell Digestiu, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Departament de Medicina, Un…. Hauptthemen laut MEDLINE: Helicobacter Infections, Peptic Ulcer, Helicobacter pylori. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Peptic ulcer disease is a frequent pathology; although the incidence has decreased in recent years, it continues to be an important cause of morbidity and mortality associated with high healthcare costs. The most important risk factors are Helicobacter pylori(H. pylori) infection and the use of non-steroidal anti-inflammatory drugs. Most patients with peptic ulcer disease remain asymptomatic, with dyspepsia being the most frequent and often characteristic symptom. It can also debut with complications such as upper gastrointestinal bleeding, perforation or stenosis. The diagnostic technique of choice is upper gastrointestinal endoscopy. Treatment with proton pump inhibitors, eradication of H. pylori and avoiding the use of non-steroidal anti-inflammatory drugs are the basis of treatment. However, prevention is the best strategy, it includes an adequate indication of proton pump inhibitors, investigation and treatment of H. pylori, avoiding non-steroidal anti-inflammatory drugs or using those that are less gastrolesive.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsPeptic UlcerHelicobacter pyloriHumansProton Pump InhibitorsAnti-Inflammatory Agents, Non-SteroidalEndoscopy, Digestive System

Stichwörter der Autor:innen

Antiinflamatorios no esteroideosCOX-2 selective inhibitorsComplicaciones gastrointestinalesGastroprotecciónGastroprotectionHelicobacter pyloriInhibidores selectivos COX-2Non-steroidal anti-inflammatory drugsPeptic ulcer diseaseUpper gastrointestinal complicationsÚlcera péptica

Substanzen

Proton Pump InhibitorsAnti-Inflammatory Agents, Non-Steroidal

Autor:innen und Institutionen

  • Servei d'Aparell Digestiu, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Departament de Medicina, Universitat Autònoma de Barcelona, Sabadell, España.
  • Servei d'Aparell Digestiu, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Departament de Medicina, Universitat Autònoma de Barcelona, Sabadell, España; Centro de Investiga…

Zitieren

APA

Laucirica, I., García Iglesias, P., & Calvet, X. (2023). Úlcera péptica. Medicina Clínica. https://doi.org/10.1016/j.medcli.2023.05.008

Vancouver

Laucirica I, García Iglesias P, Calvet X. Úlcera péptica. Medicina Clínica. 2023. doi:10.1016/j.medcli.2023.05.008

BibTeX
@article{Laucirica2023,
  author = {Laucirica, Isabel and García Iglesias, Pilar and Calvet, Xavier},
  title = {Úlcera péptica},
  journal = {Medicina Clínica},
  year = {2023},
  doi = {10.1016/j.medcli.2023.05.008}
}
Kostenlos starten →